Uveodermatologic (VKH-like) syndrome in American Akita dogs is associated with an increased frequency of DQA1*00201

Tissue Antigens

Volumn 66, Issue 6, 2005, Pages 656-665

  Angles, J M ^a   Famula, T R ^a   Pedersen, Niels C ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Canine; DLA DQA1; DLA DQB1; DLA DRB1; Uveodermatologic syndrome; VKH like

Indexed keywords

HLA ANTIGEN CLASS 2; HLA DQA1 ANTIGEN; HLA DQB1 ANTIGEN; HLA DR ANTIGEN;

ALLELE; ANIMAL CELL; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DEPIGMENTATION; DISEASE ACTIVITY; DISEASE SEVERITY; DOG; FEMALE; GENE LOCUS; GENETIC ASSOCIATION; GENETIC VARIABILITY; HOMOZYGOSITY; HUMAN; IMMUNOPATHOLOGY; MALE; MYASTHENIA GRAVIS; NONHUMAN; PATHOGENESIS; PEMPHIGUS FOLIACEUS; POLYARTHRITIS; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; THYROIDITIS; UVEITIS; UVEODERMATOLOGIC SYNDROME; VOGT KOYANAGI SYNDROME;

ALLELES; ANIMALS; DERMATITIS; DOG DISEASES; DOGS; FEMALE; GENE FREQUENCY; HAPLOTYPES; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HOMOZYGOTE; HYPOPIGMENTATION; MALE; RISK FACTORS; SYNDROME; ULTRAVIOLET RAYS; UVEITIS; UVEOMENINGOENCEPHALITIC SYNDROME;

ANIMALIA; CANIS FAMILIARIS;

EID: 27944475581     PISSN: 00012815     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-0039.2005.00508.x     Document Type: Article

References (77)

1. Pedersen NC. A review of immunologic diseases of the dog. Vet Immunol Immunopathol 1999: 69: 251-342.
2. Sutler NB, Ostrander EA. Dog rising star: the canine genetic system. Nat Rev Genet 2004: 5: 900-10.
3. Olivry T, Joubeh S, Dunston SM, Nishiyama T, Ghohestani RF. Desmoglein-3 is a target autoantigen in spontaneous canine pemphigus vulgaris. Exp Dermatol 2003: 12: 198-203.
4. Nishifuji K, Amagai M, Ota T, Nishikawa T, Iwasaki T. Cloning of canine desmoglein 3 and immunoreactivity of serum antibodies in human and canine pemphigus vulgaris with its extracellular domains. J Dermatol Sci 2003: 32: 181-91.
5. Jackson HA, Olivry T, Berget F, Dunston SM, Bonnefont C, Charbanne L. Immunopathology of vesicular cutaneous lupus erythematosus in the rough collie and Shetland sheepdog: a canine homologue of subacute cutaneous lupus erythematosus in humans. Vet Dermatol 2004: 15: 230-9.
6. Shelton GD. Acquired myasthenia gravis: what we have learned from experimental and spontaneous animal models. Vet Immunol Immunopathol 1999: 69: 239-49.
7. Shelton GD, Skeie GO, Kass PH, Aarli JA. Titin and ryanodine receptor autoantibodies in dogs with thymoma and late-onset myasthenia gravis. Vet Immunol Immunopathol 2001: 78: 97-105.
8. Irion DN, Schaffer AL, Famula TR, Eggleston ML, Hughes SS, Pedersen NC. Analysis of genetic variation in 28 dog breed populations with 100 microsatellite markers. J Heredity 2003: 94: 81-7.
9. Parker HG, Kim LV, Sutler NB et al. Genetic structure of the purebred domestic dog. Science 2004: 304: 1160-4.
10. Sutler NB, Eberle MA, Parker HG et al. Extensive and breed-specific linkage disequilibrium in Canis familiaris. Genome Res 2004: 14: 2388-96.
11. Rhoden NC. Pawprints in Japan. Dogs in Myth and History. Richmond, CA, USA: Fire Lake Press, 2002.
12. Dougherly SA, Center SA, Shaw EE, Erb HA. Juvenile-onset polyarthritis in Akitas. J Am Vet Med Assoc 1991: 198: 849-56.
13. Webb AA, Taylor SM, Muir GD. Steroid-responsive meningitis-arthritis in dogs with noninfectious, nonerosive, idiopathic, immune-mediated polyarthritis. J Vet Intern Med 2002: 16: 269-73.
14. Ihrke PJ, Stannard AA, Ardans AA, Griffin CE. Pemphigus foliaceus in dogs: a review of 37 cases. J Am Vet Med Assoc 1985: 186: 59-66.
15. Kuhl KA, Shofer FS, Goldschmidt MH. Comparative histopathology of pemphigus foliaceus and superficial folliculitis in the dog. Vet Pathol 1994: 31: 19-27.
16. Reichler IM, Hauser B, Schiller I et al. Sebaceous adenitis in the Akita: clinical observations, histopathoogy and heredity. Vet Dermatol 2001: 12: 243-53.
17. Shelton GD, Schule A, Kass PH. Risk factors for acquired myasthenia gravis in dogs: 1,154 cases (1991-1995). J Am Vet Med Assoc 1997: 211: 1428-31.
18. Shelton GD, Schule A, Kass PH. Analysis of risk factors for acquired myasthenia in dogs. Ann N Y Acad Sci 1998: 841: 587-91.
19. Bussanich MN, Rootman J, Dolman CL. Granulomatous pan uveitis and dermal depigmentation in dogs. J Am Anim Hosp Assoc 1982: 18: 131-8.
20. Kern TJ, Walton DK, Riis RC, Manning TO, Laratta LJ, Dziezyc J. Uveitis associated with poliosis and vitiligo in six dogs. J Am Vet Assoc 1985: 187: 408-14.
21. Romatowski J. A uveodermatological syndrome in an Akita dog. J Am Anim Hosp Assoc 1985: 21: 777-80.
22. Cottrell BD, Barnett KC. Harada's disease in the Japanese Akita. J Small Anim Prac 1987: 28: 517-21.
23. Morgan RV. Vogt-Koyanagi-Harada Syndrome in humans and dogs. Compend Contin Educ Pract Vet 1989: 11: 1211-8.
24. Lindley DM, Boosinger TR, Cox NR. Ocular histopathology of Vogt-Koyanagi-Harada-like syndrome in an Akita dog. Vet Pathol 1990: 27: 294-6.
25. Barros PSM, Safatle AMV, Malerba TA, Yrio K, Alvarenga J, Larsson MHMA. Uveitis and dermal depigmentation (Vogt-Koyanagi-Harada-like syndrome) in Akita dogs. I. Clinical aspects. Braz J Vet Res Anim Sci 1991: 28: 75-9.
26. Murphy CJ, Bellhorn RW, Thirkill C. Anti-retinal antibodies associated with Vogt-Koyanagi-Harada-like syndrome in a Dog. J Am Anim Hosp Assoc 1991: 27: 399-402.
27. Reusch C, Chang L, Minkus G. Vogt-Koyanagi-Harada syndrome in an Akita-Inu dog. A case report. Tierarztl Prax 1994: 22(4): 398-400. (Article in German)
28. Zavros NS, Saridomichelakis MN, Koutinas AF, Komnenou A. Uveodermatological syndrome in an Akita dog. Aust Vet Practitioner 2001: 31: 27-31.
29. Usami H, Ohshima K, Numakunai S, Naitoh Y, Okada K. A case of chronic diffuse uveitis accompanied with dermal depigmentation in Akita dog. Jap J Vet Sci 1988: 51: 215-8.
30. Read RW, Holland GN, Rao NA et al. Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: report of an international committee on nomenclature. Am J Ophthalmol 2001: 131: 647-52.
31. Yamaki K, Takiyama N, Itho N et al. Experimentally induced Vogt-Koyanagi-Harada disease in two Akita dogs. Exp Eye Res 2005: 80: 273-80.
32. Carter WJ, Crispin SM, Gould DJ, Day MJ. An immunohistochemical study of uveodermatologic syndrome in two Japanese Akita dogs. Vet Ophthalmol 2005: 8: 17-24.
33. Chan CC, Palestine AG, Kuwabara T, Nussenblatt RB. Immunopathologic studies of Vogt Koyanagi Harada syndrome. Am J Ophthalmol 1988: 105: 607-11.
34. Sakamoto T, Murata T, Inomata H. Class II major histocompatibility complex on melanocytes of Vogt Koyanagi Harada disease. Arch Ophthalmol 1991: 109: 1270-4.
35. Shindo Y, Inoko H, Yamamoto T, Ohno S. HLA-DRB1 typing of Vogt-Koyanagi-Harada's disease by PCR-RFLP and the strong association with DRB1*0405 and DRB1*0410. Br J Ophthalmol 1994a: 78: 223-6.
36. Shindo Y, Ohno S, Yamamoto T, Nakamura S, Inoko H. Complete association of the HLA-DRB1*04 and DQB1*04 alleles with Vogt-Koyanagi-Harada's disease. Hum Immunol 1994b: 39: 169-76.
37. Islam SM, Numaga J, Fujino Y et al. HLA class II genes in Vogt-Koyanagi-Harada disease. Invest Ophthalmol Vis Sci 1994: 35: 3890-6.
38. Zhao M, Jiang Y, Abrahams IW. Association of HLA antigens with Vogt-Koyanagi-Harada syndrome in a Han Chinese population. Arch Ophthalmol 1991: 109: 368-70.
39. Riddington L, Hall AJ, Tait B, Nicholson I, Varney M. Vogt-Koyanagi-Harada syndrome in patients of Vietnamese ancestry. Aust N Z J Ophthalmol 1996: 24: 147-9.
40. Pivetti-Pezzi P, Accorinti M, Colabelli-Gisoldi RA, Pirraglia MP. Vogt-Koyanagi-Harada Disease and HLA type in Italian patients. Am J Ophthalmol 1996: 122: 889-91.
41. Goldberg AC, Yamamoto JH, Chiarella JM et al. HLA-DRB1*0405 is the predominant allele in Brazilian patients with Vogt-Koyanagi-Harada disease. Hum Immunol 1998: 59: 183-8.
42. Arellanes-Garcia L, Bautista N, Mora P, Ortega-Larrocea G, Burguet A, Gorodezky C. HLA-DR is strongly associated with Vogt-Koyanagi-Harada disease in Mexican Mestizo patients. Ocul Immunol Inflamm 1998: 6: 93-100.
43. Alaez C, del Pilar Mora M, Arlellanes L et al. Strong association of HLA Class II sequences in Mexicans with Vogt-Koyanagi-Harada's disease. Hum Immunol 1999: 60: 875-82.
44. Kim MH, Seong MC, Kwak NH et al. Association of HLA with Vogt-Koyanagi-Harada Syndrome in Koreans. Am J Ophthalmol 2000: 129: 173-7.
45. Kennedy LJ, Angles JM, Barnes A et al. Nomenclature for factors of the dog major histocompatibility system (DLA). Second report of the ISAG DLA Nomenclature 2000 Committee. Anim Genet 2001a: 32: 193-7.
46. Kennedy LJ, Angles JM, Barnes A et al. Nomenclature for factors of the dog major histocompatibility system (DLA). Second report of the ISAG DLA Nomenclature 2000 Committee. Tissue Antigens 2001b: 58: 55-70.
47. Wagner JL, Burnett RC, DeRose SA, Storb R. Molecular analysis and polymorphism of the DLA-DQA gene. Tissue Antigens 1996a: 48: 199-204.
48. Wagner JL, Burnett RC, Works JD, Storb R. Molecular analysis and polymorphism of the DLA-DRBB1 polymorphism. Tissue Antigens 1996b: 48: 554-61.
49. Wagner JL, Hayes-Lattin B, Works JD, Storb R. Molecular analysis and polymorphism of the DLA-DQB genes. Tissue Antigens 1998: 52: 242-50.
50. Debenham SL, Hart EA, Ashurst JL et al. Genomic sequence of class II region of the canine MHC. comparison with other mammalian species. Genomics 2005: 85: 48-9.
51. Richards B, Skoletsky J, Schuber AP et al. Multiplex PCR amplification from the CFTR gene using DNA prepared from buccal brushes/swabs. Hum Mol Genet 1993: 2: 159-63.
52. Oberbauer AM, Grossman DI, Eggleston ML et al. Alternatives to Blood as a Source of DNA for Large-scale Scanning Studies of Canine Genome Linkages. Vet Res Comms 2003: 27: 27-38.
53. Kennedy LJ, Barnes A, Happ GM et al. Extensive interbreed, but minimal intrabreed, variation of DLA class II alleles and haplotypes in dogs. Tissue Antigens 2002: 59: 194-204.
54. Clark AG. Inference of haplotypes from PCR-amplified samples of diploid populations. Mol Biol Evol 1990: 7: 111-22.
55. Haldane JB. The estimation and significance of the logarithm of a ratio of frequencies. Ann Hum Genet 1956: 20: 309-11.
56. Edwards JH. HLA and disease: The detection of associations. J Immunogenet 1974: 1: 249-57.
57. Dorak MT. Statistical analysis in HLA and disease association studies, http://dorakmt.tripod.com/hla/stat.html.
58. Bland M. An Introduction to Medical Statistics. Oxford: Oxford University Press, 1996.
59. Altman DG. Practical Statistics for Medical Research. London: Chapman & Hall, 1992.
60. Asakura S, Takahashi T, Onishi T. Vogt-Koyanagi-Harada Syndrome (Uveitis diffusa acuta) in the Dog. Jap J Vet Med 1977: 673: 445-55 (in Japanese with English summary).
61. Izaks GJ, Remarque EJ, Schreuder GMT, Westendorp RGJ, Ligthart GJ. The effect of geographic origin on the frequency of HLA antigens and their association with ageing. Eur J Immunogenet 2000: 27: 87-92.
62. Svejgaard A, Ryder LP. HLA and disease associations: Detecting the strongest association. Tissue Antigens 1994: 43: 18-27.
63. Shindo Y, Ohno S, Nakamura S, Onoe K, Inoko H. A significant association of HLA-DPB1*0501 with Vogt-Koyanagi-Harada's disease results from a linkage disequilibrium with the primarily associated allele, DRB1*0405. Tissue Antigens 1996: 47: 344-5.
64. Lou XY, Todhunter RJ, Lin M et al. The extent and distribution of linkage disequilibrium in a multi-hierarchic outbred canine pedigree. Mamm Genome 2003: 14: 555-64.
65. Hyun C, Fihppich LJ, Lea RA, Shepherd G, Hughes IP, Griffiths LR. Prospects for whole genome linkage disequilibrium mapping in domestic dog breeds. Mamm Genome 2003: 14: 640-9.
66. Apanius V, Penn D, Slev PR, Ruff LR, Potts WK. The Nature of Selection on the Major Histocompatibility Complex. Crit Rev Immunol 1997: 17: 179-224.
67. Khan MA, Khan MM. Diagnostic value of HLA-B27 testing in anklosing spondylitis and Reiter's syndrome. Ann Intern Med 1982: 96: 70-6.
68. Norose K, Yano A. Melanoma specific Th 1 cytotoxic T lymphocyte lines in Vogt-Koyanagi-Harada disease. Br J Ophthalmol 1996: 80: 1002-8.
69. Sugita S, Sagawa K, Mochizuki M, Shichijo S, Itoh K. Melanocyte lysis by cytotoxic T lymphocytes recognizing the MART-1 melanoma antigen in HLA-A2 patients with Vogt-Koyanagi-Harada disease. Int Immunol 1996: 8: 799-803.
70. Zarour HM, Kirkwood JM, Salvucci Kierstead L et al. Melan-A/MART-151-73 represents an immunogenic HLA-DR4-restitcted epitope recognized by melanomareactive CD4+ T cells. Proc Natl Acad Sci USA 2000: 97: 400-5.
71. Kobayashi H, Kokubo T, Takahashi M et al. Tyrosinase epitope recognized by an HLA-DR-restricted T-cell line from a Vogt-Koyanagi-Harada disease patient. Immunogenetics 1998: 47: 398-403.
72. Jimenze M, Kameyama K, Maloy WL, Tomita Y, Hearing VJ. Mammalian tyrosinase: biosythesis, processing, and modulation by melanocyte-stimulating hormone. Proc Natl Acad Sci USA 1988: 85: 3830-4.
73. Dean RR, Kilduf TS, Dement WC, Grumet FC. Narcolepsy without unique MHC class II antigen association: studies in the canine model. Human Immunol 1989: 25: 27-35.
74. Lin L, Faraco J, Li R et al. The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell 1999: 98: 365-76.
75. Wagner JL, Storb R, Storer B, Mignot E. DLA-DQB1 alleles and bone marrow transplantation experiments in narcoleptic dogs. Tissue Antigens 2000: 56: 223-31.
76. Ollier WE, Kennedy LJ, Thomson W et al. Dog MHC alleles containing the human RA shared epitope confer susceptibility to canine rheumatoid arthritis. Immunogenetics 2001: 53: 669-73.
77. Quinnell RJ, Kennedy LJ, Barnes A et al. Susceptibility to visceral leishmaniasis in the domestic dog is associated with MHC class II polymorphism. Immunogenetics 2003: 55: 23-8.